Capital International, Inc./CA/
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 895213
Los Angeles, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,202,045
-$883,428 QoQ
Shares Held
13,154
+11.9% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#322
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International, Inc./CA/ holds $249,590,047 across 7 Biotechnology names. REGN ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
305,477 | $87,051,780 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
164,407 | $81,665,889 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,074,948 | $60,272,334 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
13,154 | $8,202,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,671 | $7,727,741 | |
| 6 | ASND |
Ascendis Pharma A/S
|
10,443 | $2,785,356 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
34,560 | $1,884,902 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,202,045 | 13,154 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,085,473 | 11,759 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,650,690 | 12,503 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $21,012,029 | 37,370 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $37,198,875 | 70,855 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $46,432,612 | 73,211 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $50,294,059 | 70,605 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $67,515,889 | 64,225 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $64,367,179 | 61,242 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $54,254,598 | 56,369 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $47,048,238 | 53,568 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $42,722,322 | 51,913 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,205,473 | 43,429 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $30,976,137 | 37,699 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,944,029 | 38,731 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $27,680,174 | 40,182 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $48,181,824 | 81,508 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $62,355,636 | 89,281 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $19,915,614 | 31,536 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,641,964 | 30,804 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,521,186 | 33,160 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,314,085 | 36,594 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $19,505,566 | 40,375 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $20,831,652 | 37,214 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,327,917 | 35,802 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,861,522 | 22,244 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||